WMSA
TLSI icon

Weiss Multi-Strategy Advisers’s TriSalus Life Sciences TLSI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,758
Closed -$104K – 799
2021
Q2 		$104K Hold
10,758
– – ﹤0.01% 651
2021
Q1 		$104K Buy
+10,758
New +$109K ﹤0.01% 679

Other funds holding TLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TLSI Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of TriSalus Life Sciences (TLSI) in Q3 2021, closing a stake of 10,758 shares — an estimated $104K sold.

Weiss Multi-Strategy Advisers first reported a position in TLSI in Q1 2021 and held it in 2 quarters. The position peaked at $104K in Q2 2021. 66 funds tracked by Wall St. Rank hold TLSI as of Q3 2021.

  • Weiss Multi-Strategy Advisers reported no remaining TriSalus Life Sciences position as of Q3 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,758 TriSalus Life Sciences shares in Q3 2021, an estimated $104K.
  • Weiss Multi-Strategy Advisers first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's TriSalus Life Sciences position peaked at $104K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.